<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OPINION STATEMENT: • Patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> due to atherosclerotic carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> (ACAO) should receive intravenous tissue plasminogen activator (alteplase) if they meet eligibility criteria of the National Institute of <z:e sem="disease" ids="C1112108" disease_type="Disease or Syndrome" abbrv="">Neurological Disorders</z:e> and <z:hpo ids='HP_0001297'>Stroke</z:hpo> (NINDS) or the European Cooperative <z:hpo ids='HP_0011009'>Acute</z:hpo> <z:hpo ids='HP_0001297'>Stroke</z:hpo> Study III (ECASS III). • Patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001297'>stroke</z:hpo> due to ACAO who are not eligible for intravenous tissue plasminogen activator should receive aspirin </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="5" ids="28304">Heparin</z:chebi> or <z:chebi fb="5" ids="28304">heparin</z:chebi>-like drugs do not improve outcome and should not be used. • Therapy for prevention of recurrent <z:hpo ids='HP_0001297'>stroke</z:hpo> in patients with ACAO should consist of lifestyle modifications, risk factor intervention, and antiplatelet drugs </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="8" ids="10033">Warfarin</z:chebi> is not indicated. • Extracranial-intracranial bypass surgery provides no benefit over medical therapy in preventing recurrent <z:hpo ids='HP_0001297'>stroke</z:hpo> in a general population of patients with ACAO or in any subgroups selected by clinical, arteriographic, or hemodynamic criteria. • Other surgical or endovascular procedures have no proven value in treating or preventing <z:hpo ids='HP_0001297'>stroke</z:hpo> due to ACAO. • Asymptomatic carotid occlusion has a benign prognosis and requires no specific treatment other than lifestyle modification and risk factor intervention </plain></SENT>
</text></document>